Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
320.00    0.50 (0.16%)
Bid:
319.50
Ask:
320.50
Spread: 1.00 (0.313%)
Market Cap: £738.14m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Directorate Change

1 Jul 2020 07:00

RNS Number : 5427R
Chesnara PLC
01 July 2020
 

CHESNARA plc

("Chesnara" or "the Company")

 

 

 

1 July 2020

 

LEI Number: 213800VFRMBRTSZ3SJ06

 

 

NOTICE OF CHANGES TO INDEPENDENT NON EXECUTIVE DIRECTORS

 

Chesnara plc today announces that David Brand will step down from the Board with immediate effect as, after securing regulatory approval, he takes up the role as Chairman of the Company's UK business Countrywide Assured plc.

 

As a result of this change, the Company is also pleased to announce the appointment of Eamonn Flanagan as independent Non-Executive Director with immediate effect. Eamonn will join the Chesnara plc Nomination & Governance Committee, Audit & Risk Committee and Remuneration Committee as well as becoming a NonExecutive Director on the Board and Audit & Risk Committee of Countrywide Assured plc.

 

Eamonn has extensive operational experience in financial services in roles with Royal Insurance and Charterhouse/ING Barings. He also brings executive and markets experience from Shore Capital Markets where he was a Director and co-founder, as well as Non-executive experience from AJ Bell, Randall & Quilter and previously at JLT. Eamonn is a Fellow of the Institute of Actuaries.

 

Chairman Luke Savage commented:

'David, with his wealth of experience and knowledge of the Group, will be sorely missed at the Chesnara plc Board table, but I am very pleased that he will Chair our UK business whilst also continuing to Chair our Swedish business Movestic Livförsäkring AB.

 

'I am also delighted to announce the appointment, of Eamonn who will bring valuable experience, insight and skills which will be of significant benefit to the Group.'

 

There is no further information relating to Eamonn which would require disclosure under 9.6.13R of the Listing Rules.

 

 

For further information, please contact:

 

Roddy Watt

Director, Capital Markets

FWD

Forward thinking communications

 

T - 07714 770 493

E - roddy.watt@fwdconsulting.co.uk 

 

 

Notes to Editors

Chesnara is a life and pensions company listed on the London Stock Exchange. It administers over one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.

 

Following a three pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.

 

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 15 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAFMMMTMTBJBFM
Date   Source Headline
23rd Nov 20177:30 amRNSHolding(s) in Company
23rd Nov 20177:00 amRNSResult of External Audit Tender
7th Nov 20177:00 amRNSDirector/PDMR Shareholding
1st Nov 20174:06 pmRNSTotal Voting Rights
7th Sep 20177:34 amRNSStatement re: the Legacy Review
31st Aug 20177:00 amRNSHalf-year Report
17th Aug 20174:00 pmRNSHolding(s) in Company
8th Aug 20177:00 amRNSNotice of Results
2nd Aug 20177:00 amRNSTotal Voting Rights
18th May 20177:00 amRNSResult of AGM
28th Apr 20173:26 pmRNSDirector/PDMR Shareholding
18th Apr 20177:00 amRNSAnnual Financial Report & AGM Notice
11th Apr 20172:06 pmRNSSCILDON - new name for Legal & General Nederland
6th Apr 20177:00 amRNSCompletion of LGN acquisition
31st Mar 20177:00 amRNSFinal Results
30th Mar 20175:15 pmRNSAcquisition
6th Mar 201712:11 pmRNSNotice of Results
6th Jan 20177:00 amRNSHolding(s) in Company
19th Dec 20167:00 amRNSHolding(s) in Company
16th Dec 20164:56 pmRNSUpdate on Excess Applications
16th Dec 20162:15 pmRNSHolding(s) in Company
15th Dec 20168:00 amRNSAdmission of Shares
14th Dec 20167:00 amRNSDirectorate Change
13th Dec 20164:20 pmRNS2016 EGM Results, TVR and Director Dealing
13th Dec 20167:00 amRNSResults of Placing and Open Offer
24th Nov 20165:25 pmRNSPublication of a Prospectus
24th Nov 20167:01 amRNSProposed Acquisition and Placing
22nd Nov 20167:10 amRNSStatement regarding market speculation
22nd Nov 20167:00 amRNSStatement regarding press speculation
26th Oct 20167:00 amRNSDirectorate Change
29th Sep 201610:07 amRNSHolding(s) in Company
31st Aug 20167:00 amRNSHalf-year Report
30th Aug 20167:00 amRNSHolding(s) in Company
10th Aug 201612:17 pmRNSNotice of Results
4th Jul 201610:32 amRNSHolding(s) in Company
14th Jun 20164:30 pmRNSNotification of director share interest
25th May 20161:41 pmRNSHolding(s) in Company
19th May 20167:00 amRNSDirectorate Change
19th May 20167:00 amRNSAppointment of new joint broker
19th May 20167:00 amRNSResult of AGM
28th Apr 20162:32 pmRNSDirector/PDMR Shareholding
20th Apr 20167:00 amRNSAnnual Financial Report 2015 and AGM Notice
31st Mar 20167:00 amRNSFinal Results
24th Mar 20168:45 amRNSNotice of Results
11th Mar 20163:45 pmRNSHolding(s) in Company
3rd Mar 20168:34 amRNSStatement re Legacy Review
30th Nov 20151:56 pmRNSHolding(s) in Company
19th Nov 20157:00 amRNSInterim Management Statement
13th Oct 20156:17 pmRNSHolding(s) in Company
28th Aug 20157:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.